Loading Events
  • This event has passed.

Putting Our Heads Together: Diagnostic Innovations for Alzheimer’s Disease

June 6, 2023 @ 3:00 pm - 3:45 pm EDT

Diagnostic tests and procedures offer opportunities to detect diseases, monitor disease progression, guide treatments, and evaluate treatment effectiveness. Some diagnostic tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.

Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women. Research seeking to expand the development and availability of diagnostic tools for conditions that exclusively, differently, or disproportionately affect women is invaluable in furthering women’s health across sectors.

SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events will discuss how to improve health outcomes for diseases and conditions that disproportionately or differently affect women, with special a focus on cancer and healthy aging.

The 2023 SWHR Value of Diagnostics within Women’s Health series includes:


Follow the conversation on Twitter at @SWHR and #SWHRtalksDiagnostics.

This event is free and open to the public.


June 6, 2023
3:00 pm - 3:45 pm EDT
Event Categories:
, , , ,




  • Discuss the impacts of Alzheimer’s disease on women’s health, including disparities in disease burden, mortality, and access to care
  • Provide an overview of key diagnostic considerations and disease management in women
  • Emphasize ways to empower women to adopt healthy habits that may prevent disease or delay progression
  • Highlight health care policies that present barriers to access to quality care and coverage

Are you interested in seeing more of this type of educational programming on women’s health from SWHR?



Rachel Buckley, PhD
Assistant Professor, Department of Neurology, Massachusetts General Hospital/Harvard Medical School
Rachel Buckley, PhD
Assistant Professor, Department of Neurology, Massachusetts General Hospital/Harvard Medical School

Rachel Buckley is an Assistant Professor of Neurology at Harvard Medical School, with a primary appointment at Massachusetts General Hospital. After initially completing her PhD in Neuropsychology at the University of Melbourne, Australia, with the Australian Imaging Biomarker and Lifestyle Study of Aging, she then moved to Boston to train in PET neuroimaging and cognitive decline under Dr. Reisa Sperling at the Harvard Aging Brain Study. Her research interests lie in sex differences in risk for Alzheimer’s disease, with a particular focus on women’s health (menopause and the X chromosome) and AD risk. She holds multiple NIH grants, including an NIH K99/R00 Pathway to Independence Award and DP2 New Innovator Award, as well as a fellowship from the Alzheimer’s Association, that seek to examine the role of menopause, sex hormones and the X chromosome to impact risk and resilience to AD in both men and women. Rachel is also the Vice-Chair of the Sex and Gender Differences in Alzheimer’s disease Professional Interest Area for the Alzheimer’s Association.

Heather M. Snyder, PhD
Vice President, Medical & Scientific Relations, Alzheimer's Association
Heather M. Snyder, PhD
Vice President, Medical & Scientific Relations, Alzheimer's Association

Heather Snyder is the VP of Medical and Scientific Relations at the Alzheimer’s Association. She oversees Association initiatives that accelerate Alzheimer’s research and provideopportunities for the global dementia community.  She is responsible for overseeing the progress the Association has made in Alzheimer’s and dementia research funding. She leads the Association’s International Research Grant Program and strategic funding initiatives, through which the Association funds investigations that advance understanding of Alzheimer’s and moves the field toward solutions for the global Alzheimer’s crisis. As the world’s largest nonprofit funder of Alzheimer’s research, the Association is currently investing over $300 million in more than 920 active best-of-field projects in 45 countries.

Explore previous topics from SWHR’s Value of Diagnostics within Women’s Health Series


SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains independence and editorial control over program development, content, and work products.